BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6170754)

  • 1. Antitrypsin activity and enzyme inhibitors in the rheumatoid joint.
    Robinson AD; Boyden KN; Hendrickson SM; Muirden KD
    J Rheumatol; 1981; 8(4):547-54. PubMed ID: 6170754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Macroglobulin alpha-2 in synovial fluid: relationship with reactants of the acute phase of rheumatoid arthritis].
    Seriolo B; Cutolo M; De Cesari F; Accardo S
    Medicina (Firenze); 1990; 10(4):401-2. PubMed ID: 1712420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of enzyme inhibitors in the joint in rheumatoid and experimental arthritis.
    Muirden KD; Leyden K
    Int J Tissue React; 1984; 6(5):359-65. PubMed ID: 6083987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum alpha-1-antitrypsin specific activity in monoclonal gammopathies.
    Jelić-Ivanović Z; Stanković B; Topić A; Spasojević-Kalimanovska V; Spasić S
    Panminerva Med; 2000 Mar; 42(1):17-21. PubMed ID: 11019599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of synovial fluid alpha 1-antitrypsin by exercise of the inflamed rheumatoid joint.
    Zhang Z; Farrell AJ; Blake DR; Chidwick K; Winyard PG
    FEBS Lett; 1993 Apr; 321(2-3):274-8. PubMed ID: 8477862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-2-antichymotrypsin in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kiluk S; Gluszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):817-23. PubMed ID: 2467852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of protease-inhibitor complexes from the arthritic joint.
    Ekerot L; Ohlsson K; Necking L
    Int J Tissue React; 1985; 7(5):391-5. PubMed ID: 2414244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.
    Ekerot L; Ohlsson K
    Rheumatol Int; 1982; 2(1):21-6. PubMed ID: 6184771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraarticular alpha 2-macroglobulin complexes and proteolytic activity in children with juvenile rheumatoid arthritis.
    Levine JJ; Sherry DD; Strickland DK; Ilowite NT
    Pediatr Res; 1993 Aug; 34(2):204-7. PubMed ID: 7694228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteases and their inhibitors in posttraumatic knee joint effusion].
    Kunz E; Blattert TR; Weckbach A
    Z Orthop Ihre Grenzgeb; 1996; 134(5):426-9. PubMed ID: 8967142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of N-acetylo-beta-hexosamninidase in joint fluid from knee and serum of patients with rheumatoid arthritis and osteoarthritis].
    Popko J; Zalewska A; Sierakowski S; Macias T; Knaś M; Zwierz K; Sredzińska K
    Przegl Lek; 2005; 62(7):650-2. PubMed ID: 16463694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between alpha 1-antitrypsin inactivation and tumor necrosis factor alpha concentration in the synovial fluid of patients with rheumatoid arthritis.
    Chidwick K; Whichelow CE; Zhang Z; Fairburn K; Sachs JA; Blake DR; Winyard PG
    Arthritis Rheum; 1994 Dec; 37(12):1723-6. PubMed ID: 7986217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
    Mero M; Tenhunen R; Pessi T; Sandholm M
    Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion.
    Ortutay Z; Polgár A; Gömör B; Géher P; Lakatos T; Glant TT; Gay RE; Gay S; Pállinger E; Farkas C; Farkas E; Tóthfalusi L; Kocsis K; Falus A; Buzás EI
    Arthritis Rheum; 2003 Aug; 48(8):2163-72. PubMed ID: 12905469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of metal-binding proteins and proteinase inhibitors with immunological parameters in rheumatoid synovial fluids.
    Ahmadzadeh N; Shingu M; Nobunaga M; Yasuda M
    Clin Exp Rheumatol; 1990; 8(6):547-51. PubMed ID: 1705187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between severity of rheumatoid arthritis and serum alpha 1-antitrypsin.
    Abboud RT; Chalmers A; Gofton JP; Richter AM; Enarson DA
    J Rheumatol; 1991 Oct; 18(10):1490-5. PubMed ID: 1765973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease.
    Carsons S; Mosesson MW; Diamond HS
    Arthritis Rheum; 1981 Oct; 24(10):1261-7. PubMed ID: 6975631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of proteolytic enzymes and their natural inhibitors in serum and bronchial lavage fluid in atopic bronchial asthma, chronic bronchitis and pneumonia.
    Płusa T; Tchórzewski H
    Allerg Immunol (Leipz); 1985; 31(3):169-78. PubMed ID: 2416211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.